5 results
Progression-free Survival  #EBM #Honc #Osimertinib #NSCLC #Survival #NEJM
Progression-free Survival #EBM ... #Honc #Osimertinib ... #NSCLC #Survival ... #NEJM
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer - Progression-free Survival in the Intention-to-Treat Population.
the Intention-to-Treat ... #EBM #Honc #PACIFIC ... #Durvalumab #NSCLC ... #NEJM
Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer #EBM #Honc #Alectinib #Crizotinib #ALK #ALKPositive #NSCLC
Non–Small-Cell Lung Cancer #EBM ... #Honc #Alectinib ... #ALKPositive #NSCLC ... VisualAbstract #NEJM
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma - Recurrence-free Survival in the
the Intention-to-Treat ... Population #EBM ... #Honc #Nivolumab ... Ipilimumab #Melanoma #NEJM
Radiation-Induced Angiosarcoma after Breast-Cancer Treatment - Physical examination revealed an area of skin 10 cm in
Angiosarcoma after Breast-Cancer ... cm in diameter, medial ... the dermis and breast ... Clinical #Derm #Honc ... Radiation #Microscopy #NEJM